m.dalgaard
TL3 Regular · Odense, DK
Health economist by training, which mostly means I am tedious about cost-effectiveness claims.
Joined 26 December 2024 · last posted 1d · groups: journal-club, translators
136 posts, newest first. Showing up to 150.
-
Revisiting: The best-written scientific paper you have read Replied, post #119 · Lounge › Off topic · 27 Jul 2026 · 6 likes Answering the best-written scientific paper question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on…
-
Reused chromatograms across lots: how to spot it Replied, post #59 · Analytics › COA interpretation · 20 Jul 2026 · 0 likes Summarising the reused chromatograms across lots thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
-
What is genuinely unknown about long-term amylin agonism Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 17 Jul 2026 · 0 likes Everything in post #46 holds. The case it does not cover is the one I have. Comparing an amylin analogue to an incretin agonist on weight change alone misses that they…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #6 · Clinical › Prescriber conversations · 16 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #40 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 0 likes The pulsatile character of endogenous growth hormone release is why a secretagogue and exogenous growth hormone are not interchangeable, and why a single measured level…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #42 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes Osteoarthritis and mechanical versus metabolic came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #22 · Lounge › Off topic · 9 Jul 2026 · 13 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
-
Reading a home test result without over-claiming Replied, post #107 · Analytics › Home & field testing · 5 Jul 2026 · 25 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #26 · Practice › Side effects · 2 Jul 2026 · 0 likes Answering the question post #25 raises rather than the one it answers. The published rates come from populations that were titrated on a defined schedule with clinical…
-
An 18-month record including the parts that went badly Replied, post #48 · Outcomes › Progress reports · 22 Jun 2026 · 0 likes Confirming post #45 from a second method, which matters more than confirming it from a second person. Self-reported intake is optimistic in a consistent direction, and…
-
Revisiting: The best-written scientific paper you have read Replied, post #44 · Lounge › Off topic · 21 Jun 2026 · 11 likes I would rather this thread reach "we do not know" about best-written scientific paper than reach a confident answer that nobody can support when asked.
-
Asking a follow-up: new topic or new reply? Replied, post #17 · Start Here › How to Ask · 20 Jun 2026 · 0 likes Coming back to post #13, because the follow-up matters more than the original answer. The version of asking a follow-up that I was taught turned out to be a teaching…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #27 · Pharmacology › Pharmacokinetics · 17 Jun 2026 · 8 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #2 · Practice › Interactions · 15 Jun 2026 · 8 likes Everything in the opening post holds. The case it does not cover is the one I have. Insulin interaction: semaglutide and tirzepatide are not contraindicated with…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #5 · Research Methods › N-of-1 designs · 14 Jun 2026 · 0 likes Duration should be set by how long an effect would take to appear rather than by patience. Stopping early is the commonest reason a personal experiment answers nothing.…
-
A critique that turned out to be unfair, retracted by its author Replied, post #12 · Evidence › Study critique · 14 Jun 2026 · 3 likes Adding a small correction to the critique summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #83 · Access › Insurance & coverage · 11 Jun 2026 · 0 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
-
Prescription requirements and telehealth models — a second dataset Replied, post #57 · Sourcing › Regulatory · 8 Jun 2026 · 13 likes Adding what did not work for me on Prescription requirements and telehealth models, since the failures never get written up and they are half the useful information.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #119 · Compounds › Tirzepatide · 2 Jun 2026 · 7 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Coming back to: Time to steady state after a dose increase Replied, post #67 · Pharmacology › Pharmacokinetics · 2 Jun 2026 · 30 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #66 · Start Here › Welcome · 30 May 2026 · 28 likes You do not need to introduce yourself before asking a question, and nobody will think worse of you for arriving with one. The introductions subcategory exists for…
-
Revisiting: Taste changes and food aversion, reported and discussed Started this topic · Practice › Side effects · 30 May 2026 · 53 likes Revisiting: Taste changes and food aversion, reported and discussed Writing it up because I had to work it out twice and would rather nobody else did. Two things I…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #74 · Evidence › Journal club · 26 May 2026 · 26 likes Orforglipron phase 2 is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #21 · Compounds › Oral incretins · 26 May 2026 · 0 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #15 · Practice › Side effects · 22 May 2026 · 24 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #41 · Devices › Syringes & needles · 15 May 2026 · 5 likes Adding a small correction to the 0.3 ml versus 0.5 ml summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
-
Coming back to: Time to steady state after a dose increase Replied, post #52 · Pharmacology › Pharmacokinetics · 13 May 2026 · 0 likes Body weight affects volume of distribution and therefore exposure at a fixed dose. Whether that translates into a dosing implication depends on the width of the…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #43 · Clinical › Comorbidities · 8 May 2026 · 0 likes Where I part company with post #41, and it is a narrow parting. Small methodological point on gastro-oesophageal reflux: repeating a measurement is cheap and resolves…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #4 · Analytics › Impurities & related substances · 23 Apr 2026 · 13 likes The claim about Endotoxin upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Recording a dissent on a document rather than suppressing it Replied, post #12 · Documentation › Doc review · 20 Apr 2026 · 4 likes Second maintainers matter. A single maintainer is a single point of failure and every document here that went stale had one.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #45 · Practice › Administration · 15 Apr 2026 · 4 likes Narrowing post #42, because the general version has more than one answer. If you have to inject at a different time of day than usual, that is a much smaller…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #86 · Practice › Interactions · 14 Apr 2026 · 1 like Post #83 and I disagree about the size of the effect, not about the direction. An honest declaration on anaesthesia and elective surgery: I have a prior here and it is…
-
Official shortage notices and what they authorise Replied, post #6 · Access › Shortages · 13 Apr 2026 · 24 likes Whatever the answer on official shortage notices turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #7 · Start Here › Welcome · 5 Apr 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #23 · Evidence › Journal club · 24 Mar 2026 · 6 likes Helpful, and short, which on this subject is harder than long.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #59 · Practice › Side effects · 22 Mar 2026 · 9 likes Reading rather than answering, but this is the post I would point somebody at.
-
Managing an unplanned gap in supply Replied, post #61 · Access › Shortages · 15 Mar 2026 · 9 likes Where a manufacturer publishes a supply statement, that document is more reliable than any aggregation of individual experiences. On balance I think that is right, and…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #47 · Compounds › Repair & healing peptides · 12 Mar 2026 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #44 · Practice › Storage & stability · 19 Feb 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I am aware this is the third time this…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #50 · Evidence › Study critique · 13 Feb 2026 · 0 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #63 · Practice › Storage & stability · 13 Feb 2026 · 7 likes I have been on both sides of the storing lyophilised material long term argument in this category within eighteen months, which should tell you how strong the evidence…
-
Adsorption to container surfaces and to plastics Replied, post #17 · Pharmacology › Formulation chemistry · 9 Feb 2026 · 14 likes I read post #16 twice before replying, because I had assumed the opposite. Counter-ion exchange from trifluoroacetate to acetate is a purification step with a cost, and…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #52 · Practice › Storage & stability · 5 Feb 2026 · 0 likes This follows post #50 rather than contradicting it. The useful distinction on storing lyophilised material long term is between what was measured and what was inferred…
-
Revisiting: Sample handling between despatch and injection Replied, post #7 · Analytics › Method validation · 20 Jan 2026 · 5 likes Narrowing post #4, because the general version has more than one answer. The distinction between a qualified instrument and a validated method is worth keeping. Both…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #24 · Practice › Reconstitution · 12 Jan 2026 · 4 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #39 · Meta › Site feedback · 8 Jan 2026 · 23 likes The arithmetic in post #36 is right; the assumption feeding it is the part to check. Navigation problems: if you cannot find something you expected to exist, or the…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #2 · Practice › Reconstitution · 3 Jan 2026 · 19 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #65 · Wellbeing › Mental health · 19 Dec 2025 · 0 likes Post #62 and I disagree about the size of the effect, not about the direction. If you are in crisis, contact a local emergency or crisis service rather than posting. A…
-
DXA precision and the least significant change for lean mass Replied, post #63 · Outcomes › Body composition · 12 Dec 2025 · 2 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Tracking a preprint to publication: a worked example Replied, post #103 · Evidence › Preprints · 10 Dec 2025 · 25 likes Post #100 answers the question as asked. The question underneath it is different. Where a preprint contradicts a published trial, the prior should favour the trial.…
-
Reading an interaction checker output critically Replied, post #53 · Practice › Interactions · 28 Nov 2025 · 20 likes Everything in post #51 holds. The case it does not cover is the one I have. Anything that also slows gut motility compounds the same mechanism. That is a plausibility…
-
Documentation that materially improves an appeal's chances Replied, post #80 · Access › Insurance & coverage · 27 Nov 2025 · 1 like On post #77 — agreed on the reasoning, with one qualification. I changed my mind about documentation after someone here asked me for the source and I could not produce…
-
Persistent vomiting and the threshold for seeking help Replied, post #67 · Safety › Adverse events · 11 Nov 2025 · 4 likes Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety surveillance. This is the version I would want a new member to…
-
Sleep tracking data and its considerable limitations Replied, post #119 · Wellbeing › Sleep · 29 Oct 2025 · 0 likes Post #117 and I disagree about the size of the effect, not about the direction. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #42 · Clinical › Special populations · 28 Oct 2025 · 7 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Comparing my trajectory with the trial curves, carefully Replied, post #64 · Outcomes › Progress reports · 20 Oct 2025 · 27 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #11 · Compounds › Tirzepatide · 19 Oct 2025 · 2 likes Gastrointestinal effects were comparable in character to the GLP-1 monoagonists across the programme. Individual reports here vary in both directions, which is what you…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #6 · marked as the solution · Compounds › Tirzepatide · 18 Oct 2025 · 13 likes Worth separating two things that post #2 runs together. Comparisons between the tirzepatide and semaglutide programmes across trials rather than within one are weak.…
-
Adolescents: a distinct evidence base — one year on Replied, post #22 · Clinical › Special populations · 5 Oct 2025 · 4 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. I have deliberately not…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #69 · Practice › Storage & stability · 5 Oct 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Documentation that appears only after payment Replied, post #40 · Sourcing › Red flags · 4 Oct 2025 · 0 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #112 · Evidence › Preprints · 4 Oct 2025 · 7 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. The rule…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Insomnia at a dose step: reported experiences Replied, post #13 · Wellbeing › Sleep · 26 Sep 2025 · 9 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Needle changes between doses on a reusable pen Replied, post #37 · Devices › Pens & autoinjectors · 22 Sep 2025 · 7 likes The click count on a dialled pen is a mechanical property of that pen and is not a universal unit. Counting clicks across two different devices is not a conversion.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #50 · Practice › Administration · 6 Sep 2025 · 24 likes Post #47 answers the question as asked. The question underneath it is different. The single most common technique error described here is drawing to the wrong…
-
Immortal time bias in a claims-database study Replied, post #31 · Evidence › Study critique · 26 Aug 2025 · 0 likes Small methodological point on immortal time bias: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Are there stupid questions here? A staff answer, at length Replied, post #113 · Start Here › Welcome · 25 Aug 2025 · 12 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #73 · Compounds › Secretagogues & GH axis · 17 Aug 2025 · 8 likes Storage: these are lyophilised short peptides and are generally reasonably stable dry and considerably less so in solution. Reconstituting only what will be used within…
-
Titles that describe the question, not the situation Replied, post #68 · Start Here › How to Ask · 10 Aug 2025 · 20 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it. The rule…
-
Triple agonism: additive, synergistic, or neither? Replied, post #77 · Compounds › Retatrutide · 9 Aug 2025 · 12 likes Two claims get bundled together under triple agonism and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #21 · Practice › Side effects · 7 Aug 2025 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #47 · Analytics › Home & field testing · 5 Aug 2025 · 0 likes Quantitation: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
What pooling buys you and what it destroys Started this topic · Evidence › Meta-analyses · 3 Aug 2025 · 24 likes The question in the title: What pooling buys you and what it destroys I will give what I have already checked below so nobody repeats it. The question about pooling…
-
Holding a dose indefinitely: is there a documented downside? Replied, post #33 · Practice › Dosing & titration · 3 Aug 2025 · 8 likes Post #31 describes the usual case. This is about the unusual one. Going back down a step is not a failure and the trials allowed it. Several protocols permitted a…
-
A ten-fold dose error caught before injection — one year on Replied, post #12 · Devices › Syringes & needles · 1 Aug 2025 · 23 likes Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
-
Are there stupid questions here? A staff answer, at length Replied, post #26 · Start Here › Welcome · 30 Jul 2025 · 6 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Foaming during reconstitution and whether it matters Replied, post #21 · Practice › Reconstitution · 28 Jul 2025 · 0 likes Building on post #18 rather than restating it. Marking my uncertainty on foaming during reconstitution explicitly. I am confident about the direction, much less…
-
Are there stupid questions here? A staff answer, at length Replied, post #17 · Start Here › Welcome · 27 Jul 2025 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Persistent vomiting and the threshold for seeking help Replied, post #9 · Safety › Adverse events · 23 Jul 2025 · 25 likes This is the sort of exchange that makes the archive worth searching.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #22 · Analytics › HPLC & UHPLC · 22 Jul 2025 · 10 likes No notes. Posting so the count is not one.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #52 · Devices › Cold chain · 19 Jul 2025 · 0 likes Agreed on Airline travel, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
-
Triple agonism: additive, synergistic, or neither? Replied, post #68 · Compounds › Retatrutide · 16 Jul 2025 · 3 likes Narrowing post #67, because the general version has more than one answer. Practical experience of triple agonism, offered as one case with the conditions stated, not as…
-
Coming back to: When "no data" is the complete and final answer Replied, post #46 · Compounds › Other compounds · 15 Jul 2025 · 0 likes This follows post #43 rather than contradicting it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #14 · Compounds › Repair & healing peptides · 30 Jun 2025 · 21 likes Post #10 and I disagree about the size of the effect, not about the direction. Oral versus injected administration claims for BPC-157: the preclinical work studied…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #120 · Compounds › Tirzepatide · 26 Jun 2025 · 11 likes Adding the measurement that post #119 says would settle it. Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #87 · Nutrition & Training › Protein & intake · 14 Jun 2025 · 30 likes I had written a reply contradicting post #83 and deleted it. Here is what survived. I read the earlier replies on Tracking intake twice before writing this, because I…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 8 likes That is a cleaner way of putting what I was circling around.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #42 · Compounds › Oral incretins · 4 Jun 2025 · 29 likes I had written a reply contradicting post #40 and deleted it. Here is what survived. Orforglipron is a small molecule, not a peptide. That changes almost everything: no…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #127 · Evidence › Journal club · 30 May 2025 · 4 likes Two claims get bundled together under SURMOUNT-1 and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #103 · Sourcing › Red flags · 29 May 2025 · 32 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not.
-
A friction point in the promotion workflow — the long version Replied, post #5 · Meta › Site feedback · 28 May 2025 · 3 likes That is the distinction I keep failing to hold on to. Written down now.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #88 · Data & Tools › Calculators · 24 May 2025 · 4 likes That is a fair summary of where the discussion has got to.
-
When to stop reading forums, including this one — the long version Replied, post #25 · Wellbeing › Mental health · 20 May 2025 · 24 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment. Adding it…
-
Pregnancy as an absolute contraindication Replied, post #99 · Safety › Contraindications · 20 May 2025 · 0 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #5 · Sourcing › Regulatory · 14 May 2025 · 32 likes Careful with the language on compound being unapproved. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Residual solvents and scavengers: what is looked for Replied, post #23 · Analytics › Impurities & related substances · 13 May 2025 · 18 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #41 · Compounds › Retatrutide · 12 May 2025 · 5 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
A well-designed study with a badly written abstract Replied, post #42 · Evidence › Study critique · 24 Apr 2025 · 0 likes I had written a reply contradicting post #38 and deleted it. Here is what survived. Building consensus on which criticisms matter: if everyone agrees that the sample…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #41 · Compounds › Tirzepatide · 18 Apr 2025 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Started this topic · Evidence › Journal club · 16 Apr 2025 · 0 likes Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Working notes on STEP 1…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #17 · Clinical › Comorbidities · 13 Apr 2025 · 0 likes Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #33 · Wellbeing › Mental health · 13 Apr 2025 · 8 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well. Someone should write this up…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #11 · Devices › Syringes & needles · 8 Apr 2025 · 2 likes Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly, which is the entire trade.
-
One lot is one lot: when a report becomes a pattern — the long version Started this topic · Sourcing › Vendor reports · 14 Mar 2025 · 20 likes One lot is one lot: when a report becomes a pattern — the long version — setting out what I have, and where I think it stops being reliable. Structured report rather…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #109 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes Taking post #106 at face value and following it one step further. What would change my mind on pharmaceutical compounding rules is a second dataset collected by someone…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #10 · Practice › Dosing & titration · 21 Feb 2025 · 1 like Worth separating two things that post #8 runs together. The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #16 · Documentation › Doc review · 9 Feb 2025 · 26 likes Coming back to post #12, because the follow-up matters more than the original answer. Agreed on draft on reconstitution arithmetic, with one qualification that I think…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #77 · Compounds › Other compounds · 30 Jan 2025 · 2 likes That is clearer than the version I had in my head. Thank you.
-
What a seizure notice actually says Replied, post #25 · Sourcing › Logistics · 18 Jan 2025 · 13 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance. I would not lead a decision with this, but I would not…
-
[2026 update] New subcategory: rationale and scope Replied, post #155 · Meta › Announcements · 16 Jan 2025 · 11 likes My position on New subcategory is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #92 · Compounds › Tirzepatide · 30 Dec 2024 · 31 likes Answering the question post #91 raises rather than the one it answers. Having read the whole SURPASS-2 thread before replying: the question in the first post has not…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #17 · Sourcing › Vendor reports · 27 Dec 2024 · 15 likes Coming back to post #13, because the follow-up matters more than the original answer. Genuine question rather than a rhetorical one: has anyone here actually observed…
-
UK access routes, dated and sourced — a second dataset Replied, post #20 · Regional › UK & Ireland · 27 Dec 2024 · 5 likes Where a member reports a decision, the useful detail is the stated reason rather than the outcome, because the reason is what generalises. This is the sort of thing the…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #29 · Evidence › Trials · 11 Dec 2024 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #24 · Evidence › Journal club · 7 Dec 2024 · 1 like Picking up post #21: that is the part I would want checked first. Assigning the statistics to somebody who will read the analysis plan rather than the results section…
-
Two sessions a week versus four: what the evidence supports Replied, post #25 · Nutrition & Training › Resistance training · 6 Dec 2024 · 0 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop. That is the honest state of it…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #129 · Analytics › COA interpretation · 25 Nov 2024 · 0 likes Confirming post #126 from a second method, which matters more than confirming it from a second person. Adding a reference point for field-by-field walk through a…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #56 · Clinical › Special populations · 24 Nov 2024 · 0 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. The absence of a reported signal in a population that was barely enrolled is not…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #91 · Compounds › Repair & healing peptides · 19 Nov 2024 · 29 likes The preclinical work is genuinely interesting and it is preclinical. A rodent tendon model is a model of a rodent tendon, and the translation record from that kind of…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #5 · Compounds › Repair & healing peptides · 19 Nov 2024 · 14 likes Post #4 is the version of this I will quote in future. One addition. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue…
-
Why I ask for the gradient before I discuss the number Replied, post #34 · Analytics › HPLC & UHPLC · 8 Nov 2024 · 8 likes A relative retention time against a known peak travels much better than an absolute one, and almost nobody reports it.
-
Time to steady state after a dose increase Replied, post #163 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 16 likes That reframing is the whole thing. The facts I already had.
-
Requesting a page: what makes a good request — what changed since Replied, post #133 · Documentation › Wiki requests · 13 Oct 2024 · 14 likes Taking post #130 at face value and following it one step further. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #13 · Compounds › Secretagogues & GH axis · 30 Sep 2024 · 12 likes Practical note on pulsatile secretion: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…
-
Merging two pages that cover the same ground — the long version Replied, post #6 · Documentation › Wiki requests · 25 Sep 2024 · 0 likes Useful. I have added it to my own notes with the date on it.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #47 · Clinical › Bloodwork · 22 Sep 2024 · 3 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Progressive overload when the scale is falling — one year on Replied, post #64 · Nutrition & Training › Resistance training · 17 Sep 2024 · 0 likes Speaking only to Progressive overload as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests,…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #90 · Nutrition & Training › Hydration & electrolytes · 12 Sep 2024 · 7 likes Symptoms attributed to electrolytes here are non-specific and overlap with dehydration, low intake and poor sleep. Attribution from symptoms alone is unreliable.…
-
Correlation in a self-tracked dataset: what it can support Replied, post #38 · Research Methods › Statistics · 21 Aug 2024 · 3 likes An observation about correlation that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #7 · Compounds › Semaglutide · 14 Aug 2024 · 0 likes On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal trials show. What they show is that the effect persists while…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #48 · Analytics › COA interpretation · 12 Aug 2024 · 9 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #20 · Practice › Interactions · 9 Jul 2024 · 10 likes A definition problem is doing most of the work in this oral contraceptives and delayed emptying discussion. Once the term is pinned down I suspect the disagreement…
-
Taste changes and food aversion, reported and discussed Started this topic · Practice › Side effects · 4 Jul 2024 · 0 likes Posting this under the heading it deserves: Taste changes and food aversion, reported and discussed Everything below is what sits behind that. The question about taste…
-
How this community labels and discusses unrefereed work Replied, post #20 · Evidence › Preprints · 15 Jun 2024 · 27 likes Post #17 is right about the mechanism and I think understates the practical bit. A preprint with the data and code attached is frequently more checkable than a…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #8 · Practice › Dosing & titration · 2 Jun 2024 · 0 likes The confident answers on four-week escalation interval and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…